S&P 500   3,967.02 (+0.09%)
DOW   33,756.04 (-0.08%)
QQQ   284.75 (+0.32%)
AAPL   144.00 (+0.95%)
MSFT   247.32 (-0.03%)
META   116.53 (+1.04%)
GOOGL   94.04 (+0.35%)
AMZN   89.66 (-0.76%)
TSLA   181.75 (+4.79%)
NVDA   174.11 (+1.41%)
NIO   13.04 (-2.76%)
BABA   93.15 (-1.08%)
AMD   70.01 (-0.65%)
T   19.31 (+0.99%)
MU   55.41 (+0.38%)
CGC   3.00 (-2.91%)
F   13.33 (+1.60%)
GE   82.49 (-1.36%)
DIS   94.18 (+1.76%)
AMC   6.02 (-0.82%)
PYPL   74.31 (+0.12%)
PFE   51.86 (+0.15%)
NFLX   324.97 (+4.74%)
S&P 500   3,967.02 (+0.09%)
DOW   33,756.04 (-0.08%)
QQQ   284.75 (+0.32%)
AAPL   144.00 (+0.95%)
MSFT   247.32 (-0.03%)
META   116.53 (+1.04%)
GOOGL   94.04 (+0.35%)
AMZN   89.66 (-0.76%)
TSLA   181.75 (+4.79%)
NVDA   174.11 (+1.41%)
NIO   13.04 (-2.76%)
BABA   93.15 (-1.08%)
AMD   70.01 (-0.65%)
T   19.31 (+0.99%)
MU   55.41 (+0.38%)
CGC   3.00 (-2.91%)
F   13.33 (+1.60%)
GE   82.49 (-1.36%)
DIS   94.18 (+1.76%)
AMC   6.02 (-0.82%)
PYPL   74.31 (+0.12%)
PFE   51.86 (+0.15%)
NFLX   324.97 (+4.74%)
S&P 500   3,967.02 (+0.09%)
DOW   33,756.04 (-0.08%)
QQQ   284.75 (+0.32%)
AAPL   144.00 (+0.95%)
MSFT   247.32 (-0.03%)
META   116.53 (+1.04%)
GOOGL   94.04 (+0.35%)
AMZN   89.66 (-0.76%)
TSLA   181.75 (+4.79%)
NVDA   174.11 (+1.41%)
NIO   13.04 (-2.76%)
BABA   93.15 (-1.08%)
AMD   70.01 (-0.65%)
T   19.31 (+0.99%)
MU   55.41 (+0.38%)
CGC   3.00 (-2.91%)
F   13.33 (+1.60%)
GE   82.49 (-1.36%)
DIS   94.18 (+1.76%)
AMC   6.02 (-0.82%)
PYPL   74.31 (+0.12%)
PFE   51.86 (+0.15%)
NFLX   324.97 (+4.74%)
S&P 500   3,967.02 (+0.09%)
DOW   33,756.04 (-0.08%)
QQQ   284.75 (+0.32%)
AAPL   144.00 (+0.95%)
MSFT   247.32 (-0.03%)
META   116.53 (+1.04%)
GOOGL   94.04 (+0.35%)
AMZN   89.66 (-0.76%)
TSLA   181.75 (+4.79%)
NVDA   174.11 (+1.41%)
NIO   13.04 (-2.76%)
BABA   93.15 (-1.08%)
AMD   70.01 (-0.65%)
T   19.31 (+0.99%)
MU   55.41 (+0.38%)
CGC   3.00 (-2.91%)
F   13.33 (+1.60%)
GE   82.49 (-1.36%)
DIS   94.18 (+1.76%)
AMC   6.02 (-0.82%)
PYPL   74.31 (+0.12%)
PFE   51.86 (+0.15%)
NFLX   324.97 (+4.74%)
NASDAQ:SWAV

ShockWave Medical - SWAV Stock Forecast, Price & News

$231.47
-7.44 (-3.11%)
(As of 12/9/2022 11:10 AM ET)
Add
Compare
Today's Range
$229.53
$238.77
50-Day Range
$232.70
$296.82
52-Week Range
$113.36
$320.54
Volume
4,168 shs
Average Volume
385,815 shs
Market Capitalization
$8.37 billion
P/E Ratio
99.34
Dividend Yield
N/A
Price Target
$263.00

ShockWave Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.63 Rating Score
Upside/​Downside
10.1% Upside
$263.00 Price Target
Short Interest
Healthy
3.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$13.73 M Sold Last Quarter
Proj. Earnings Growth
21.23%
From $2.92 to $3.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

Medical Sector

296th out of 1,022 stocks

Surgical & Medical Instruments Industry

35th out of 101 stocks

SWAV stock logo

About ShockWave Medical (NASDAQ:SWAV) Stock

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

The Critical Minerals Race: U.S. v China
The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.
The Critical Minerals Race: U.S. v China
The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.
Merit Medical's (MMSI) New Launch to Boost Patient Outcome
Here's Why You Should Hold on to Abiomed (ABMD) Stock Now
Medtronic (MDT) Q2 Earnings Beat Estimates, Margins Down
Shockwave Medical (SWAV) Beats on Q3 Earnings & Revenues
ShockWave Medical (SWAV) Q3 2022 Earnings Call Transcript
Earnings Preview: ShockWave Medical
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings
11/08/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/16/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
657
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$263.00
High Stock Price Forecast
$338.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
+13.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

Net Income
$-9,140,000.00
Pretax Margin
20.75%

Debt

Sales & Book Value

Annual Sales
$237.15 million
Book Value
$6.85 per share

Miscellaneous

Free Float
34,732,000
Market Cap
$8.37 billion
Optionable
Not Optionable
Beta
0.95

Key Executives

  • Mr. Douglas E. Godshall M.B.A. (Age 57)
    Pres, CEO & Director
    Comp: $1.4M
  • Mr. Daniel Puckett MBA (Age 58)
    CFO, Principal Financial Officer & Sec.
    Comp: $658.71k
  • Mr. Isaac ZachariasMr. Isaac Zacharias (Age 47)
    Chief Commercial Officer
    Comp: $679.54k
  • Mr. Daniel Hawkins (Age 55)
    Founder and Sr. Advisor
  • Mr. John M. Adams (Age 75)
    Co-Founder and Technical Advisor
  • Mr. Mike Maszy
    VP of Operations
  • Ms. Trinh PhungMs. Trinh Phung (Age 44)
    Chief Accounting Officer, Principal Accounting Officer & VP of Fin.
  • Ms. Debbie Kaster
    VP of Investor Relations
  • Mr. Hajime Tada J.D.
    Gen. Counsel & Sec.
  • Mr. Rob Williamson Jr.
    VP of Sales













SWAV Stock - Frequently Asked Questions

Should I buy or sell ShockWave Medical stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is ShockWave Medical's stock price forecast for 2023?

8 brokerages have issued 12-month target prices for ShockWave Medical's shares. Their SWAV share price forecasts range from $165.00 to $338.00. On average, they anticipate the company's share price to reach $263.00 in the next twelve months. This suggests a possible upside of 10.1% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2022?

ShockWave Medical's stock was trading at $178.33 at the beginning of 2022. Since then, SWAV stock has increased by 34.0% and is now trading at $238.91.
View the best growth stocks for 2022 here
.

When is ShockWave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our SWAV earnings forecast
.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, November, 8th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.12. The business earned $65.16 million during the quarter, compared to analysts' expectations of $61.21 million. ShockWave Medical had a trailing twelve-month return on equity of 30.08% and a net margin of 20.48%. The firm's quarterly revenue was up 232.6% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.38) earnings per share.

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical updated its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $483.00 million-$488.00 million, compared to the consensus revenue estimate of $475.94 million.

What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are ShockWave Medical's major shareholders?

ShockWave Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.18%), Vanguard Group Inc. (9.77%), Price T Rowe Associates Inc. MD (4.97%), State Street Corp (3.20%), Macquarie Group Ltd. (2.67%) and Artisan Partners Limited Partnership (1.85%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of ShockWave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $238.91.

How much money does ShockWave Medical make?

ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $8.63 billion and generates $237.15 million in revenue each year. The company earns $-9,140,000.00 in net income (profit) each year or $2.33 on an earnings per share basis.

How many employees does ShockWave Medical have?

The company employs 657 workers across the globe.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (510) 279-4262 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 12/9/2022 by MarketBeat.com Staff